371 related articles for article (PubMed ID: 27296521)
21. Disease characterization using LQTS-specific induced pluripotent stem cells.
Egashira T; Yuasa S; Suzuki T; Aizawa Y; Yamakawa H; Matsuhashi T; Ohno Y; Tohyama S; Okata S; Seki T; Kuroda Y; Yae K; Hashimoto H; Tanaka T; Hattori F; Sato T; Miyoshi S; Takatsuki S; Murata M; Kurokawa J; Furukawa T; Makita N; Aiba T; Shimizu W; Horie M; Kamiya K; Kodama I; Ogawa S; Fukuda K
Cardiovasc Res; 2012 Sep; 95(4):419-29. PubMed ID: 22739119
[TBL] [Abstract][Full Text] [Related]
22. Regenerative Therapy for Cardiomyopathies.
Wang Z; Su X; Ashraf M; Kim IM; Weintraub NL; Jiang M; Tang Y
J Cardiovasc Transl Res; 2018 Oct; 11(5):357-365. PubMed ID: 29744805
[TBL] [Abstract][Full Text] [Related]
23. Cardiovascular Disease Modeling Using Patient-Specific Induced Pluripotent Stem Cells.
Tanaka A; Yuasa S; Node K; Fukuda K
Int J Mol Sci; 2015 Aug; 16(8):18894-922. PubMed ID: 26274955
[TBL] [Abstract][Full Text] [Related]
24. Endothelin-1 induces myofibrillar disarray and contractile vector variability in hypertrophic cardiomyopathy-induced pluripotent stem cell-derived cardiomyocytes.
Tanaka A; Yuasa S; Mearini G; Egashira T; Seki T; Kodaira M; Kusumoto D; Kuroda Y; Okata S; Suzuki T; Inohara T; Arimura T; Makino S; Kimura K; Kimura A; Furukawa T; Carrier L; Node K; Fukuda K
J Am Heart Assoc; 2014 Nov; 3(6):e001263. PubMed ID: 25389285
[TBL] [Abstract][Full Text] [Related]
25. MHC-mismatched Allotransplantation of Induced Pluripotent Stem Cell-derived Cardiomyocyte Sheets to Improve Cardiac Function in a Primate Ischemic Cardiomyopathy Model.
Kashiyama N; Miyagawa S; Fukushima S; Kawamura T; Kawamura A; Yoshida S; Eiraku S; Harada A; Matsunaga K; Watabe T; Toda K; Hatazawa J; Sawa Y
Transplantation; 2019 Aug; 103(8):1582-1590. PubMed ID: 31107828
[TBL] [Abstract][Full Text] [Related]
26. Neonatal Transplantation Confers Maturation of PSC-Derived Cardiomyocytes Conducive to Modeling Cardiomyopathy.
Cho GS; Lee DI; Tampakakis E; Murphy S; Andersen P; Uosaki H; Chelko S; Chakir K; Hong I; Seo K; Chen HV; Chen X; Basso C; Houser SR; Tomaselli GF; O'Rourke B; Judge DP; Kass DA; Kwon C
Cell Rep; 2017 Jan; 18(2):571-582. PubMed ID: 28076798
[TBL] [Abstract][Full Text] [Related]
27. Generation of patient-specific induced pluripotent stem cell-derived cardiomyocytes as a cellular model of arrhythmogenic right ventricular cardiomyopathy.
Ma D; Wei H; Lu J; Ho S; Zhang G; Sun X; Oh Y; Tan SH; Ng ML; Shim W; Wong P; Liew R
Eur Heart J; 2013 Apr; 34(15):1122-33. PubMed ID: 22798562
[TBL] [Abstract][Full Text] [Related]
28. Exosomes Generated From iPSC-Derivatives: New Direction for Stem Cell Therapy in Human Heart Diseases.
Jung JH; Fu X; Yang PC
Circ Res; 2017 Jan; 120(2):407-417. PubMed ID: 28104773
[TBL] [Abstract][Full Text] [Related]
29. iPSC-derived cardiomyocytes reveal abnormal TGF-β signalling in left ventricular non-compaction cardiomyopathy.
Kodo K; Ong SG; Jahanbani F; Termglinchan V; Hirono K; InanlooRahatloo K; Ebert AD; Shukla P; Abilez OJ; Churko JM; Karakikes I; Jung G; Ichida F; Wu SM; Snyder MP; Bernstein D; Wu JC
Nat Cell Biol; 2016 Oct; 18(10):1031-42. PubMed ID: 27642787
[TBL] [Abstract][Full Text] [Related]
30. Toward Personalized Medicine: Using Cardiomyocytes Differentiated From Urine-Derived Pluripotent Stem Cells to Recapitulate Electrophysiological Characteristics of Type 2 Long QT Syndrome.
Jouni M; Si-Tayeb K; Es-Salah-Lamoureux Z; Latypova X; Champon B; Caillaud A; Rungoat A; Charpentier F; Loussouarn G; Baró I; Zibara K; Lemarchand P; Gaborit N
J Am Heart Assoc; 2015 Sep; 4(9):e002159. PubMed ID: 26330336
[TBL] [Abstract][Full Text] [Related]
31. Modelling sarcomeric cardiomyopathies with human cardiomyocytes derived from induced pluripotent stem cells.
Sewanan LR; Campbell SG
J Physiol; 2020 Jul; 598(14):2909-2922. PubMed ID: 30624779
[TBL] [Abstract][Full Text] [Related]
32. Leducq Transatlantic Network of Excellence to Cure Phospholamban-Induced Cardiomyopathy (CURE-PLaN).
Doevendans PA; Glijnis PC; Kranias EG
Circ Res; 2019 Sep; 125(7):720-724. PubMed ID: 31513489
[TBL] [Abstract][Full Text] [Related]
33. Energy utilization of induced pluripotent stem cell-derived cardiomyocyte in Fabry disease.
Chou SJ; Yu WC; Chang YL; Chen WY; Chang WC; Chien Y; Yen JC; Liu YY; Chen SJ; Wang CY; Chen YH; Niu DM; Lin SJ; Chen JW; Chiou SH; Leu HB
Int J Cardiol; 2017 Apr; 232():255-263. PubMed ID: 28082092
[TBL] [Abstract][Full Text] [Related]
34. Human embryonic stem cells vs human induced pluripotent stem cells for cardiac repair.
Barad L; Schick R; Zeevi-Levin N; Itskovitz-Eldor J; Binah O
Can J Cardiol; 2014 Nov; 30(11):1279-87. PubMed ID: 25442431
[TBL] [Abstract][Full Text] [Related]
35. Therapeutic Transdifferentiation: A Novel Approach for Ischemic Syndromes.
Connell JP; Kodali S; Cooke JP
Methodist Debakey Cardiovasc J; 2015; 11(3):176-80. PubMed ID: 26634026
[TBL] [Abstract][Full Text] [Related]
36. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
37. Autologous c-Kit+ Mesenchymal Stem Cell Injections Provide Superior Therapeutic Benefit as Compared to c-Kit+ Cardiac-Derived Stem Cells in a Feline Model of Isoproterenol-Induced Cardiomyopathy.
Taghavi S; Sharp TE; Duran JM; Makarewich CA; Berretta RM; Starosta T; Kubo H; Barbe M; Houser SR
Clin Transl Sci; 2015 Oct; 8(5):425-31. PubMed ID: 25684108
[TBL] [Abstract][Full Text] [Related]
38. Regenerative Medicine/Cardiac Cell Therapy: Pluripotent Stem Cells.
Duran AG; Reidell O; Stachelscheid H; Klose K; Gossen M; Falk V; Röll W; Stamm C
Thorac Cardiovasc Surg; 2018 Jan; 66(1):53-62. PubMed ID: 29216651
[TBL] [Abstract][Full Text] [Related]
39. Genetic Correction of Induced Pluripotent Stem Cells From a Deaf Patient With MYO7A Mutation Results in Morphologic and Functional Recovery of the Derived Hair Cell-Like Cells.
Tang ZH; Chen JR; Zheng J; Shi HS; Ding J; Qian XD; Zhang C; Chen JL; Wang CC; Li L; Chen JZ; Yin SK; Huang TS; Chen P; Guan MX; Wang JF
Stem Cells Transl Med; 2016 May; 5(5):561-71. PubMed ID: 27013738
[TBL] [Abstract][Full Text] [Related]
40. Applications of human-induced pluripotent stem cells in the investigation of inherited cardiomyopathy.
Zhao Q; Cai H; Zhan Y; Li B; Hu S; Sun N
Int J Cardiol; 2014 Dec; 177(2):604-6. PubMed ID: 25286769
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]